20 Nov 2000
| by MATTHEW ARNOLD
LONDON: The blueprint for anti-impotence drugs such as Viagra is up for grabs in the UK, where a court last week stripped Pfizer of its patent on the drug's design.
20 Nov 2000
Colle & McVoy Marketing Communications, which earlier this year began offering pet insurance to its employees (PRWeek, June 19, 2000), is up to its old furry friends-loving tricks again. This time, the funky Minneapolis agency has used trained dogs to deliver press releases for client Pfizer Animal...
13 Nov 2000
| by JULIA HOOD
WASHINGTON: Drug companies have moved to reassure consumers by voluntarily removing products containing phenylpropanolamine (PPA) from stores. This despite the fact that some believe the ingredient is not a risk when used correctly.
13 Nov 2000
| by JULIA HOOD
WHITEHOUSE STATION, NJ: A former US Social Security Administration deputy commissioner has been hired by pharmaceutical giant Merck as corporate communications VP.
06 Nov 2000
| by JULIA HOOD
NEW YORK: Manning, Selvage & Lee has hired Harriet Shelare as VP to handle the weighty task of media relations for Pharmacia's blockbuster arthritis drug, Celebrex.
06 Nov 2000
| by CRAIG MCGUIRE
Client: Just For Men Haircolor (White Plains, NY)
16 Oct 2000
The FDA s recent approval of the abortion pill mifepristone, more commonly known as RU-486, brings with it several important communications issues, the least of which is the never-ending debate over abortion itself.
16 Oct 2000
KRISTIN HANSEN, Media Director, Family Research Council
09 Oct 2000
| by DAVID E. ROVELLA
PR agency DDB Issues & Advocacy was hired earlier this year to campaign for a favorable FDA decision and on the agency's approval of US sale of the pill, to market it to healthcare professionals, said DDB senior vice president Arlene Fairfield.
Fairfield, in charge of a six-member PR team spread...